That 1 employee was probably the largest billing ivf doctor in the country. That sort of key person risk is certainly significant (obviously), but this company now is priced for such risk. 10% FCF Yield. As per fy results, Strong growth in kl, south aus, nsw, tas. Further growth opportunities overseas. Takeover possibility, strong tailwinds. Opportunities for cost cutting, nice cpi increase in prices. Genea bought out at a similar price to mvf currently despite half the size.
Agm guidance will be crucial. I think market pricing in further disappointment.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.010(1.35%) |
Mkt cap ! $292.2M | |||
| Open | High | Low | Value | Volume |
| 74.0¢ | 76.5¢ | 73.5¢ | $1.473M | 1.953M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 213316 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 14661 | 2 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| MVF (ASX) Chart |